ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 274553 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 274553; 2) Community: the network communities that were significantly associated with the response to NSC 274553; 3) Molecule: the relationships between components within communities and NSC 274553; 4) MDR: the compounds that were significantly associated with the NSC 274553.

NSC Compound Enrichment Correlation
NSC 747180 Null 0.0385613993886 0.044054657
NSC 156215 Streptovaricin complex, fraction b 0.0385613993886001 0.39210265
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0385613993886001 -0.15823828
NSC 303861 L-Cysteine analog 0.0385613993886001 0.48697316
NSC 328410 Camptothecin Derivative 0.0385613993886001 0.019450729
NSC 45236 Null 0.0385613993886001 0.053235522
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0385613993886001 0.4030149
NSC 641454 3'-O-(Dimethylaminoethylcarbonyl)-(Z)-combretastatin A-4 0.0385613993886001 0.19524026
NSC 642947 Methanone, [3-(dibromomethyl)-6-chloroquinolin-2-yl] phenyl- 0.0385613993886001 0.19482546
NSC 649904 Cyclopentanone, 5-[(4-morpholinyl)methyl]-2-pentylidene-, hydrochloride 0.0385613993886001 0.58025078
Total:105  Current:78    [First] [Prev] [Next] [Last]